In Brief: Haemonetics
This article was originally published in The Gray Sheet
Haemonetics: Receives FDA 510(k) clearance for its apheresis red cell collection devices for "automated, simultaneous collection of one unit of red blood cells and two units of plasma." The firm also announces the formation of Haemonetics Plasma Products Services, to be based in Lille, France, "to provide assistance, concrete expertise and partnership in the various steps of the continuous process from the collection of blood plasma through to its conversion into fractioned and purified plasma products"...
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.